Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05318625 | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05969405 | Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy | unknown | — | 400 | Far Eastern Memorial HospitalOTHER | 1 |
| Aug 1, 2023 |
| clinicaltrials |
| NCT05078307 | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids(VAPOHYSTERO) | unknown | N/A | 54 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05955079 | Circulating Tumor DNA Study in Patients With Endometrial Cancer(ctDNA-endo) | unknown | — | 130 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05904977 | Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer | unknown | — | 460 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05894915 | Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach | unknown | N/A | 390 | Peking University People's HospitalOTHER | 0 | Jun 8, 2023 | clinicaltrials |
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT) | unknown | Phase 1 / Phase 2 | 200 | Western Sydney Local Health DistrictOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883670 | Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer | unknown | — | 118 | Shandong UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05881967 | Molecular Mechanism Study of Uterine Sarcoma | unknown | — | 300 | Shixuan WangOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05879796 | Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer | unknown | — | 30 | Peking University Third HospitalOTHER | 0 | May 30, 2023 | clinicaltrials |
| NCT05606263 | Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer(GCR-05) | unknown | Phase 2 | 55 | Xi'an Jiaotong UniversityOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05863260 | Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer | unknown | — | 60 | Fudan UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05863377 | Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer | unknown | — | 450 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05216913 | Optimising Cardiovascular Health in Endometrial Cancer Survivors(OPTIMUS) | unknown | — | 80 | University of ManchesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05824494 | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | unknown | Phase 2 | 58 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 6, 2023 | clinicaltrials |
| NCT04240262 | Microwave Ablation for Leiomyoma(MYOMIC2) | unknown | — | 200 | Karolinska InstitutetOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05812677 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | unknown | Phase 3 | 77 | Samsung Medical CenterOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05695690 | Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification | unknown | — | 43 | Assiut UniversityOTHER | 0 | Apr 11, 2023 | clinicaltrials |
| NCT05807672 | Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer(MARF-E) | unknown | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05806125 | Clinical Value of the Fertility-preserving Surgery in Cervical Cancer | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT00492778 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | unknown | Phase 2 | 165 | GOG FoundationNETWORK | 2 | Mar 29, 2023 | clinicaltrials |
| NCT05789628 | Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT02599116 | Gastrointestinal Microbiome Study of Appendiceal Cancer | unknown | N/A | 24 | Mercy Medical CenterOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05783986 | Developing a MRI-based Deep Learning Model to Predict MMR Status | unknown | — | 600 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 24, 2023 | clinicaltrials |
| NCT05620355 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | unknown | Phase 3 | 312 | Bio Genuine (Shanghai) Biotech Co., Ltd.INDUSTRY | 1 | Mar 21, 2023 | clinicaltrials |
| NCT01881659 | Cervical Cancer Screening With Human Papillomavirus Testing(ESTAMPA) | unknown | — | 50,000 | International Agency for Research on CancerOTHER | 9 | Mar 14, 2023 | clinicaltrials |
| NCT05755893 | Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 | unknown | — | 100 | Assiut UniversityOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05741671 | Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management(MYOVASC) | unknown | — | 760 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05193669 | Clinical Validation of Molecular Triage in HR-HPV Positive Women(VALTRIHP) | unknown | — | 23,941 | Hiantis SrlINDUSTRY | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04689178 | Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women(IMPACTGP) | unknown | N/A | 195,000 | Nantes University HospitalOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05287048 | Evaluation of MCM5 in Postmenopausal Bleeding Patients | unknown | — | 2,000 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05707312 | Staging Endometrial caNcer Based on molEcular ClAssification | unknown | — | 1,032 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | unknown | Phase 3 | 498 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05602831 | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer | unknown | — | 108 | Fudan UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05437692 | Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 19 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05570331 | Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women | unknown | — | 2,200 | Ding MaOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT05561413 | Gynaecology Exercise and Mindfulness Study(GEMS) | unknown | N/A | 40 | University of UlsterOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05560035 | The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | unknown | N/A | 60 | General Hospital of Ningxia Medical UniversityOTHER | 0 | Sep 29, 2022 | clinicaltrials |
| NCT05557565 | A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer | unknown | Phase 2 | 150 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05532930 | An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)(EMPIRIC) | unknown | — | 40 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Sep 8, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT04641728 | Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer | unknown | Phase 2 | 28 | Saitama Medical University International Medical CenterOTHER | 1 | Aug 9, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Aug 3, 2023source: clinicaltrials